Anna Partyka

10PUBLICATIONS
33CO-AUTHORS
Biologically active moleculesToxicology (incl. clinical toxicology)PharmacogenomicsBiomolecular modelling and designCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 30, 2025
Correction: Compound PZ-1262, a 4-isoquinoline-sulfonamide analog of Brexpiprazole, produces potential antidepressant, anxiolytic and procognitive effects in rodent models.

Anna Partyka, Joanna Gołębiowska, Krzysztof Marciniec

|Mar 11, 2025
Compound PZ-1262, a 4-isoquinoline-sulfonamide analog of Brexpiprazole, produces potential antidepressant, anxiolytic and procognitive effects in rodent models.

Anna Partyka, Joanna Gołębiowska, Krzysztof Marciniec

|Jun 01, 2023
Selective 5-HT6 Receptor Ligands (Agonist and Antagonist) Show Different Effects on Antipsychotic Drug-Induced Metabolic Dysfunctions in Rats.

Anna Partyka, Katarzyna Górecka, Joanna Gdula-Argasińska

|Nov 11, 2022
New, Eco-Friendly Method for Synthesis of 3-Chlorophenyl and 1,1'-Biphenyl Piperazinylhexyl Trazodone Analogues with Dual 5-HT1A/5-HT7 Affinity and Its Antidepressant-like Activity.

Przemysław Zaręba, Anna Partyka, Gniewomir Latacz

|Oct 13, 2021
The Phenoxyalkyltriazine Antagonists for 5-HT6 Receptor with Promising Procognitive and Pharmacokinetic Properties In Vivo in Search for a Novel Therapeutic Approach to Dementia Diseases.

Sylwia Sudoł, Agnieszka Cios, Magdalena Jastrzębska-Więsek

|Jul 13, 2021
A new class of 5-HT1A receptor antagonists with procognitive and antidepressant properties.

Agnieszka Jankowska, Grzegorz Satała, Artur Świerczek

Pageof 2

Frequent Collaborators

6 joint publications

Magdalena Jastrzębska-Więsek

5 joint publications

Anna Wesołowska

3 joint publications

Gniewomir Latacz

3 joint publications

Paweł Zajdel